Biotech hope gets DKK 24 million from US venture fund, Væsktfonden and others
Antag Therapeutics, which is developing a treatment for obesity and diabetes with the help of the man who discovered GLP-1 hormones, has gained some new investors.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.